Haukeland Universitetssykehus, Kirurgisk serviceklinikk, Nasjonalt kompetansesenter for helsetjenestens kommunikasjonsberedskap
Bergen, 5021, Norway
NCT Number: NCT04648449
More than 12.000 patients suffer acute stroke in Norway every year, but less than half of them reach hospital within the current treatment window for thrombolysis. Stroke is the third-highest cause of death and the number one cause of severe disability requiring long time care at institutions. Consequently this has a high impact on society, patients and relatives, in addition to high costs related to care estimated to approximately 10 billion NOK per year. Although there are few studies on emergency medical communication centres (EMCC) in Norway, some have shown that the performance of the emergency medical communication centres can be improved. This project will seek to amend EMCC´s handling of acute stroke inquiries using artificial intelligence (AI), thus contributing to getting the patient to hospital in time for optimal treatments.
This study is active but is not currently recruiting participants.
18 year and older
All sexes
Observational
Bergen, 5021, Norway
In this project, the investigators will collect data from all stroke patients discharged from Helse Bergen in 2019 (approx. 1000 patients) via the Norwegian Stroke Registry (NSR). For these patients, structured hospital data from Helse Bergen will be retrieved, and based on these and the spoken content of their emergency call regarding the stroke, the investigators will use machine learning to calculate the stroke risk. The connection of historical hospital data to the spoken words in the emergency call, amplifies the analysis of emergency calls in a novel way, in comparison to sound analysis alone.
After retrieving and connecting stroke patient data, the investigators train the deep network using data from 2019. Accordingly, testing will be performed based on patients from the first half of 2020. A separation of the data into training, test, and validation assures that our trained network does not over fit on the training data and can reproduce similar results on previously unseen patients. Finally, the investigators will compare the performance of the AI with the current system through statistical analyses on data from a period of approximately one year of live usage of the AI in AMK Bergen. This will enable us to evaluate to what degree the system is able to improve within the decision process of the EMCC operators in terms of sensitivity and specificity.
Summarized, the primary objective is to build a robust, working prototype of an AI system capable of real-time identification of acute stroke for improved assessment in emergency medical calls.
Our secondary objectives are:
The anticipated result is to deliver fast (i.e. seconds) prediction scores to assist the EMCC operator in recognizing acute stroke patients, which provides an improved sensitivity and specificity compared to manual assessment only.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
AI listens to all calls to Bergen EMCC, detecting calls regarding possible stroke.
Time frame: Sept. 22 - Sept. 23
Survey AI's ability to recognize stroke, compared to the current system
Haukeland University Hospital
Other
Artificial Intelligence (AI) Support in Medical Emergency Calls - "The AISMEC-study" -Can Artificial Intelligence Improve the Precision in Identifying Acute Stroke in Emergency Medical Calls?
Acronym: AISMEC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06941753
Brain Diseases, Cardiovascular Diseases
Beijing, Beijing Municipality, China
View Trial DetailsNCT05332652
Brain Diseases, Cardiovascular Diseases
Singapore
View Trial DetailsNCT04118998
Brain Diseases, Cardiovascular Diseases
Chicago, Illinois, United States
View Trial DetailsNCT05797792
Brain Diseases, Cardiovascular Diseases
A Coruña, Spain
View Trial Details